Cyclacel Pharmaceuticals, Inc. (CYCC)
NASDAQ: CYCC · Real-Time Price · USD
0.2807
+0.0022 (0.79%)
Apr 28, 2025, 9:43 AM EDT - Market open

Cyclacel Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
582383938
Upgrade
Market Cap Growth
-13.14%-13.14%-67.46%-78.45%2.15%229.64%
Upgrade
Enterprise Value
55-1-3-15-116
Upgrade
Last Close Price
0.280.382.6710.0058.35117.15
Upgrade
PS Ratio
34.6954.986.48---
Upgrade
PB Ratio
-26.56-1.094.480.531.031.14
Upgrade
P/TBV Ratio
--4.480.531.031.14
Upgrade
EV/Sales Ratio
1269.91-----
Upgrade
Debt / Equity Ratio
--0.060.010.000.03
Upgrade
Asset Turnover
0.010.010.02---
Upgrade
Quick Ratio
0.500.500.773.067.4413.97
Upgrade
Current Ratio
0.590.590.913.257.5614.27
Upgrade
Return on Equity (ROE)
---272.63%-79.05%-52.03%-37.57%
Upgrade
Return on Assets (ROA)
-116.33%-116.33%-86.33%-48.56%-35.01%-25.51%
Upgrade
Return on Capital (ROIC)
---190.64%-64.30%-38.85%-28.17%
Upgrade
Earnings Yield
-19.42%-474.28%-828.75%-253.45%-47.57%-22.23%
Upgrade
FCF Yield
-13.84%-337.99%-592.23%-249.10%-47.85%-21.14%
Upgrade
Buyback Yield / Dilution
-529.44%-529.44%-13.38%-26.10%-145.67%-345.23%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q